Craft

PharmAthene

Total Funding

$19.3 M

Revenue

($68 K)

FY, 2022

PharmAthene Summary

Company Summary

Overview
PharmAthene is a company that develops medical solutions to augment health security. It offers the following products a recombinant protective antigen (rPA) anthrax vaccine, a bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents, and a monoclonal antibody for the prevention and treatment of anthrax infection.
Type
Private
Status
Closed
Founded
2001
HQ
Annapolis, MD, US | view all locations
Website
http://pharmathene.com/
Cybersecurity rating
Sectors

Key People

  • Mitchel Sayare, Executive Chairman of the Board

    • David J. Drutz, Director

      • Philip Hodges, Director

        • Klaus O. Schafer, Director

          LocationsView all

          1 location detected

          • Annapolis, MD HQ

            United States

            One Park Place

          PharmAthene Financials

          Summary Financials

          Revenue (Q3, 2023)
          $362.0K
          Net income (Q3, 2023)
          ($20.7M)
          Cash (Q3, 2023)
          $86.9M
          EBIT (Q3, 2023)
          ($22.5M)

          Footer menu